Influenza Vaccines
The global Influenza Vaccines market was valued at 3453.47 Million USD in 2021 and will grow with a CAGR of 4.54% from 2021 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The CDC estimates that vaccination against influenza reduces sickness, medical visits, hospitalizations, and deaths. When an immunized worker does catch the flu, they are on average back at work a half day sooner. Vaccine effectiveness in those under two years old and over 65 years old remains unknown due to the low quality of the research. needs update][8][needs update] Vaccinating children may protect those around them. The World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) recommend yearly vaccination for nearly all people over the age of six months, especially those at high risk. The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare. The vaccines are generally safe. Fever occurs in five to ten percent of children vaccinated. Temporary muscle pains or feelings of tiredness may occur as well. In certain years, the vaccine has been linked to an increase in Guillain-Barré syndrome among older people at a rate of about one case per million doses. It should not be given to those with severe allergies to eggs or to previous versions of the vaccine. The vaccines come in both inactive and weakened viral forms. The inactive version should be used for those who are pregnant. They come in forms that are injected into a muscle, sprayed into the nose, or injected into the middle layer of the skin. Vaccination against influenza began in the 1930s with large scale availability in the United States beginning in 1945. It is on the World Health Organization`s List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale price in the developing world is about $5.25 USD per dose as of 2014.In the United States, it costs less than $25 USD as of 2015.
By Market Verdors
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Altimmune
BionVax
FluGen
FOLIA BIOTECH
Genentech
Green Cross
Medicago
Moderna Therapeutics
Novavax
Shijiazhuang Yiling Pharmaceutical
SK Chemicals
UNM Pharma
Vaccitech
Vaxart
Vaxine Pty
Visterra
By Types
Trivalent Flu Vaccines
Quadrivalent Flu Vaccines
By Applications
Adults
Pediatrics
Key Indicators Analysed
Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.
Opportunities and DriversIdentifying the Growing Demands and New Technology
Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Influenza Vaccines Market Size Analysis from 2022 to 2027
1.5.1 Global Influenza Vaccines Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Influenza Vaccines Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Influenza Vaccines Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Influenza Vaccines Industry Impact
Chapter 2 Global Influenza Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Influenza Vaccines (Volume and Value) by Type
2.1.1 Global Influenza Vaccines Consumption and Market Share by Type (2016-2021)
2.1.2 Global Influenza Vaccines Revenue and Market Share by Type (2016-2021)
2.2 Global Influenza Vaccines (Volume and Value) by Application
2.2.1 Global Influenza Vaccines Consumption and Market Share by Application (2016-2021)
2.2.2 Global Influenza Vaccines Revenue and Market Share by Application (2016-2021)
2.3 Global Influenza Vaccines (Volume and Value) by Regions
2.3.1 Global Influenza Vaccines Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Influenza Vaccines Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Influenza Vaccines Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Influenza Vaccines Consumption by Regions (2016-2021)
4.2 North America Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
4.10 South America Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Influenza Vaccines Market Analysis
5.1 North America Influenza Vaccines Consumption and Value Analysis
5.1.1 North America Influenza Vaccines Market Under COVID-19
5.2 North America Influenza Vaccines Consumption Volume by Types
5.3 North America Influenza Vaccines Consumption Structure by Application
5.4 North America Influenza Vaccines Consumption by Top Countries
5.4.1 United States Influenza Vaccines Consumption Volume from 2016 to 2021
5.4.2 Canada Influenza Vaccines Consumption Volume from 2016 to 2021
5.4.3 Mexico Influenza Vaccines Consumption Volume from 2016 to 2021
Chapter 6 East Asia Influenza Vaccines Market Analysis
6.1 East Asia Influenza Vaccines Consumption and Value Analysis
6.1.1 East Asia Influenza Vaccines Market Under COVID-19
6.2 East Asia Influenza Vaccines Consumption Volume by Types
6.3 East Asia Influenza Vaccines Consumption Structure by Application
6.4 East Asia Influenza Vaccines Consumption by Top Countries
6.4.1 China Influenza Vaccines Consumption Volume from 2016 to 2021
6.4.2 Japan Influenza Vaccines Consumption Volume from 2016 to 2021
6.4.3 South Korea Influenza Vaccines Consumption Volume from 2016 to 2021
Chapter 7 Europe Influenza Vaccines Market Analysis
7.1 Europe Influenza Vaccines Consumption and Value Analysis
7.1.1 Europe Influenza Vaccines Market Under COVID-19
7.2 Europe Influenza Vaccines Consumption Volume by Types
7.3 Europe Influenza Vaccines Consumption Structure by Application
7.4 Europe Influenza Vaccines Consumption by Top Countries
7.4.1 Germany Influenza Vaccines Consumption Volume from 2016 to 2021
7.4.2 UK Influenza Vaccines Consumption Volume from 2016 to 2021
7.4.3 France Influenza Vaccines Consumption Volume from 2016 to 2021
7.4.4 Italy Influenza Vaccines Consumption Volume from 2016 to 2021
7.4.5 Russia Influenza Vaccines Consumption Volume from 2016 to 2021
7.4.6 Spain Influenza Vaccines Consumption Volume from 2016 to 2021
7.4.7 Netherlands Influenza Vaccines Consumption Volume from 2016 to 2021
7.4.8 Switzerland Influenza Vaccines Consumption Volume from 2016 to 2021
7.4.9 Poland Influenza Vaccines Consumption Volume from 2016 to 2021
Chapter 8 South Asia Influenza Vaccines Market Analysis
8.1 South Asia Influenza Vaccines Consumption and Value Analysis
8.1.1 South Asia Influenza Vaccines Market Under COVID-19
8.2 South Asia Influenza Vaccines Consumption Volume by Types
8.3 South Asia Influenza Vaccines Consumption Structure by Application
8.4 South Asia Influenza Vaccines Consumption by Top Countries
8.4.1 India Influenza Vaccines Consumption Volume from 2016 to 2021
8.4.2 Pakistan Influenza Vaccines Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Influenza Vaccines Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Influenza Vaccines Market Analysis
9.1 Southeast Asia Influenza Vaccines Consumption and Value Analysis
9.1.1 Southeast Asia Influenza Vaccines Market Under COVID-19
9.2 Southeast Asia Influenza Vaccines Consumption Volume by Types
9.3 Southeast Asia Influenza Vaccines Consumption Structure by Application
9.4 Southeast Asia Influenza Vaccines Consumption by Top Countries
9.4.1 Indonesia Influenza Vaccines Consumption Volume from 2016 to 2021
9.4.2 Thailand Influenza Vaccines Consumption Volume from 2016 to 2021
9.4.3 Singapore Influenza Vaccines Consumption Volume from 2016 to 2021
9.4.4 Malaysia Influenza Vaccines Consumption Volume from 2016 to 2021
9.4.5 Philippines Influenza Vaccines Consumption Volume from 2016 to 2021
9.4.6 Vietnam Influenza Vaccines Consumption Volume from 2016 to 2021
9.4.7 Myanmar Influenza Vaccines Consumption Volume from 2016 to 2021
Chapter 10 Middle East Influenza Vaccines Market Analysis
10.1 Middle East Influenza Vaccines Consumption and Value Analysis
10.1.1 Middle East Influenza Vaccines Market Under COVID-19
10.2 Middle East Influenza Vaccines Consumption Volume by Types
10.3 Middle East Influenza Vaccines Consumption Structure by Application
10.4 Middle East Influenza Vaccines Consumption by Top Countries
10.4.1 Turkey Influenza Vaccines Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Influenza Vaccines Consumption Volume from 2016 to 2021
10.4.3 Iran Influenza Vaccines Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Influenza Vaccines Consumption Volume from 2016 to 2021
10.4.5 Israel Influenza Vaccines Consumption Volume from 2016 to 2021
10.4.6 Iraq Influenza Vaccines Consumption Volume from 2016 to 2021
10.4.7 Qatar Influenza Vaccines Consumption Volume from 2016 to 2021
10.4.8 Kuwait Influenza Vaccines Consumption Volume from 2016 to 2021
10.4.9 Oman Influenza Vaccines Consumption Volume from 2016 to 2021
Chapter 11 Africa Influenza Vaccines Market Analysis
11.1 Africa Influenza Vaccines Consumption and Value Analysis
11.1.1 Africa Influenza Vaccines Market Under COVID-19
11.2 Africa Influenza Vaccines Consumption Volume by Types
11.3 Africa Influenza Vaccines Consumption Structure by Application
11.4 Africa Influenza Vaccines Consumption by Top Countries
11.4.1 Nigeria Influenza Vaccines Consumption Volume from 2016 to 2021
11.4.2 South Africa Influenza Vaccines Consumption Volume from 2016 to 2021
11.4.3 Egypt Influenza Vaccines Consumption Volume from 2016 to 2021
11.4.4 Algeria Influenza Vaccines Consumption Volume from 2016 to 2021
11.4.5 Morocco Influenza Vaccines Consumption Volume from 2016 to 2021
Chapter 12 Oceania Influenza Vaccines Market Analysis
12.1 Oceania Influenza Vaccines Consumption and Value Analysis
12.2 Oceania Influenza Vaccines Consumption Volume by Types
12.3 Oceania Influenza Vaccines Consumption Structure by Application
12.4 Oceania Influenza Vaccines Consumption by Top Countries
12.4.1 Australia Influenza Vaccines Consumption Volume from 2016 to 2021
12.4.2 New Zealand Influenza Vaccines Consumption Volume from 2016 to 2021
Chapter 13 South America Influenza Vaccines Market Analysis
13.1 South America Influenza Vaccines Consumption and Value Analysis
13.1.1 South America Influenza Vaccines Market Under COVID-19
13.2 South America Influenza Vaccines Consumption Volume by Types
13.3 South America Influenza Vaccines Consumption Structure by Application
13.4 South America Influenza Vaccines Consumption Volume by Major Countries
13.4.1 Brazil Influenza Vaccines Consumption Volume from 2016 to 2021
13.4.2 Argentina Influenza Vaccines Consumption Volume from 2016 to 2021
13.4.3 Columbia Influenza Vaccines Consumption Volume from 2016 to 2021
13.4.4 Chile Influenza Vaccines Consumption Volume from 2016 to 2021
13.4.5 Venezuela Influenza Vaccines Consumption Volume from 2016 to 2021
13.4.6 Peru Influenza Vaccines Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Influenza Vaccines Consumption Volume from 2016 to 2021
13.4.8 Ecuador Influenza Vaccines Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Influenza Vaccines Business
14.1 AstraZeneca
14.1.1 AstraZeneca Company Profile
14.1.2 AstraZeneca Influenza Vaccines Product Specification
14.1.3 AstraZeneca Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 CSL
14.2.1 CSL Company Profile
14.2.2 CSL Influenza Vaccines Product Specification
14.2.3 CSL Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 GlaxoSmithKline
14.3.1 GlaxoSmithKline Company Profile
14.3.2 GlaxoSmithKline Influenza Vaccines Product Specification
14.3.3 GlaxoSmithKline Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Sanofi
14.4.1 Sanofi Company Profile
14.4.2 Sanofi Influenza Vaccines Product Specification
14.4.3 Sanofi Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Altimmune
14.5.1 Altimmune Company Profile
14.5.2 Altimmune Influenza Vaccines Product Specification
14.5.3 Altimmune Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 BionVax
14.6.1 BionVax Company Profile
14.6.2 BionVax Influenza Vaccines Product Specification
14.6.3 BionVax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 FluGen
14.7.1 FluGen Company Profile
14.7.2 FluGen Influenza Vaccines Product Specification
14.7.3 FluGen Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 FOLIA BIOTECH
14.8.1 FOLIA BIOTECH Company Profile
14.8.2 FOLIA BIOTECH Influenza Vaccines Product Specification
14.8.3 FOLIA BIOTECH Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Genentech
14.9.1 Genentech Company Profile
14.9.2 Genentech Influenza Vaccines Product Specification
14.9.3 Genentech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Green Cross
14.10.1 Green Cross Company Profile
14.10.2 Green Cross Influenza Vaccines Product Specification
14.10.3 Green Cross Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Medicago
14.11.1 Medicago Company Profile
14.11.2 Medicago Influenza Vaccines Product Specification
14.11.3 Medicago Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Moderna Therapeutics
14.12.1 Moderna Therapeutics Company Profile
14.12.2 Moderna Therapeutics Influenza Vaccines Product Specification
14.12.3 Moderna Therapeutics Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Novavax
14.13.1 Novavax Company Profile
14.13.2 Novavax Influenza Vaccines Product Specification
14.13.3 Novavax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Shijiazhuang Yiling Pharmaceutical
14.14.1 Shijiazhuang Yiling Pharmaceutical Company Profile
14.14.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Specification
14.14.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 SK Chemicals
14.15.1 SK Chemicals Company Profile
14.15.2 SK Chemicals Influenza Vaccines Product Specification
14.15.3 SK Chemicals Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 UNM Pharma
14.16.1 UNM Pharma Company Profile
14.16.2 UNM Pharma Influenza Vaccines Product Specification
14.16.3 UNM Pharma Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 Vaccitech
14.17.1 Vaccitech Company Profile
14.17.2 Vaccitech Influenza Vaccines Product Specification
14.17.3 Vaccitech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 Vaxart
14.18.1 Vaxart Company Profile
14.18.2 Vaxart Influenza Vaccines Product Specification
14.18.3 Vaxart Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 Vaxine Pty
14.19.1 Vaxine Pty Company Profile
14.19.2 Vaxine Pty Influenza Vaccines Product Specification
14.19.3 Vaxine Pty Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.20 Visterra
14.20.1 Visterra Company Profile
14.20.2 Visterra Influenza Vaccines Product Specification
14.20.3 Visterra Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Influenza Vaccines Market Forecast (2022-2027)
15.1 Global Influenza Vaccines Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Influenza Vaccines Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
15.2 Global Influenza Vaccines Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Influenza Vaccines Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Influenza Vaccines Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Influenza Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Influenza Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Influenza Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Influenza Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Influenza Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Influenza Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Influenza Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Influenza Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Influenza Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Influenza Vaccines Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Influenza Vaccines Consumption Forecast by Type (2022-2027)
15.3.2 Global Influenza Vaccines Revenue Forecast by Type (2022-2027)
15.3.3 Global Influenza Vaccines Price Forecast by Type (2022-2027)
15.4 Global Influenza Vaccines Consumption Volume Forecast by Application (2022-2027)
15.5 Influenza Vaccines Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
List of Figure
Figure Product Picture
Figure North America Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure United States Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Canada Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Mexico Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure East Asia Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure China Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Japan Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure South Korea Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Europe Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Germany Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure UK Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure France Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Italy Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Russia Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Spain Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Netherlands Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Switzerland Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Poland Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure South Asia Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure India Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Pakistan Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Bangladesh Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Southeast Asia Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Indonesia Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Thailand Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Singapore Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Malaysia Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Philippines Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Vietnam Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Myanmar Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Middle East Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Turkey Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Saudi Arabia Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Iran Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure United Arab Emirates Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Israel Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Iraq Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Qatar Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Kuwait Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Oman Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Africa Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Nigeria Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure South Africa Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Egypt Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Algeria Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Algeria Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Oceania Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Australia Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure New Zealand Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure South America Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Brazil Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Argentina Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Columbia Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Chile Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Venezuela Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Peru Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Puerto Rico Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Ecuador Influenza Vaccines Revenue ($) and Growth Rate (2022-2027)
Figure Global Influenza Vaccines Market Size Analysis from 2022 to 2027 by Consumption Volume
Figure Global Influenza Vaccines Market Size Analysis from 2022 to 2027 by Value
Table Global Influenza Vaccines Price Trends Analysis from 2022 to 2027
Table Global Influenza Vaccines Consumption and Market Share by Type (2016-2021)
Table Global Influenza Vaccines Revenue and Market Share by Type (2016-2021)
Table Global Influenza Vaccines Consumption and Market Share by Application (2016-2021)
Table Global Influenza Vaccines Revenue and Market Share by Application (2016-2021)
Table Global Influenza Vaccines Consumption and Market Share by Regions (2016-2021)
Table Global Influenza Vaccines Revenue and Market Share by Regions (2016-2021)
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Major Manufacturers Capacity and Total Capacity
Table 2016-2021 Major Manufacturers Capacity Market Share
Table 2016-2021 Major Manufacturers Production and Total Production
Table 2016-2021 Major Manufacturers Production Market Share
Table 2016-2021 Major Manufacturers Revenue and Total Revenue
Table 2016-2021 Major Manufacturers Revenue Market Share
Table 2016-2021 Regional Market Capacity and Market Share
Table 2016-2021 Regional Market Production and Market Share
Table 2016-2021 Regional Market Revenue and Market Share
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table Global Influenza Vaccines Consumption by Regions (2016-2021)
Figure Global Influenza Vaccines Consumption Share by Regions (2016-2021)
Table North America Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
Table East Asia Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
Table Europe Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
Table South Asia Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
Table Southeast Asia Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
Table Middle East Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
Table Africa Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
Table Oceania Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
Table South America Influenza Vaccines Sales, Consumption, Export, Import (2016-2021)
Figure North America Influenza Vaccines Consumption and Growth Rate (2016-2021)
Figure North America Influenza Vaccines Revenue and Growth Rate (2016-2021)
Table North America Influenza Vaccines Sales Price Analysis (2016-2021)
Table North America Influenza Vaccines Consumption Volume by Types
Table North America Influenza Vaccines Consumption Structure by Application
Table North America Influenza Vaccines Consumption by Top Countries
Figure United States Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Canada Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Mexico Influenza Vaccines Consumption Volume from 2016 to 2021
Figure East Asia Influenza Vaccines Consumption and Growth Rate (2016-2021)
Figure East Asia Influenza Vaccines Revenue and Growth Rate (2016-2021)
Table East Asia Influenza Vaccines Sales Price Analysis (2016-2021)
Table East Asia Influenza Vaccines Consumption Volume by Types
Table East Asia Influenza Vaccines Consumption Structure by Application
Table East Asia Influenza Vaccines Consumption by Top Countries
Figure China Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Japan Influenza Vaccines Consumption Volume from 2016 to 2021
Figure South Korea Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Europe Influenza Vaccines Consumption and Growth Rate (2016-2021)
Figure Europe Influenza Vaccines Revenue and Growth Rate (2016-2021)
Table Europe Influenza Vaccines Sales Price Analysis (2016-2021)
Table Europe Influenza Vaccines Consumption Volume by Types
Table Europe Influenza Vaccines Consumption Structure by Application
Table Europe Influenza Vaccines Consumption by Top Countries
Figure Germany Influenza Vaccines Consumption Volume from 2016 to 2021
Figure UK Influenza Vaccines Consumption Volume from 2016 to 2021
Figure France Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Italy Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Russia Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Spain Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Netherlands Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Switzerland Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Poland Influenza Vaccines Consumption Volume from 2016 to 2021
Figure South Asia Influenza Vaccines Consumption and Growth Rate (2016-2021)
Figure South Asia Influenza Vaccines Revenue and Growth Rate (2016-2021)
Table South Asia Influenza Vaccines Sales Price Analysis (2016-2021)
Table South Asia Influenza Vaccines Consumption Volume by Types
Table South Asia Influenza Vaccines Consumption Structure by Application
Table South Asia Influenza Vaccines Consumption by Top Countries
Figure India Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Pakistan Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Bangladesh Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Southeast Asia Influenza Vaccines Consumption and Growth Rate (2016-2021)
Figure Southeast Asia Influenza Vaccines Revenue and Growth Rate (2016-2021)
Table Southeast Asia Influenza Vaccines Sales Price Analysis (2016-2021)
Table Southeast Asia Influenza Vaccines Consumption Volume by Types
Table Southeast Asia Influenza Vaccines Consumption Structure by Application
Table Southeast Asia Influenza Vaccines Consumption by Top Countries
Figure Indonesia Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Thailand Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Singapore Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Malaysia Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Philippines Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Vietnam Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Myanmar Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Middle East Influenza Vaccines Consumption and Growth Rate (2016-2021)
Figure Middle East Influenza Vaccines Revenue and Growth Rate (2016-2021)
Table Middle East Influenza Vaccines Sales Price Analysis (2016-2021)
Table Middle East Influenza Vaccines Consumption Volume by Types
Table Middle East Influenza Vaccines Consumption Structure by Application
Table Middle East Influenza Vaccines Consumption by Top Countries
Figure Turkey Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Saudi Arabia Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Iran Influenza Vaccines Consumption Volume from 2016 to 2021
Figure United Arab Emirates Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Israel Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Iraq Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Qatar Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Kuwait Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Oman Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Africa Influenza Vaccines Consumption and Growth Rate (2016-2021)
Figure Africa Influenza Vaccines Revenue and Growth Rate (2016-2021)
Table Africa Influenza Vaccines Sales Price Analysis (2016-2021)
Table Africa Influenza Vaccines Consumption Volume by Types
Table Africa Influenza Vaccines Consumption Structure by Application
Table Africa Influenza Vaccines Consumption by Top Countries
Figure Nigeria Influenza Vaccines Consumption Volume from 2016 to 2021
Figure South Africa Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Egypt Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Algeria Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Algeria Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Oceania Influenza Vaccines Consumption and Growth Rate (2016-2021)
Figure Oceania Influenza Vaccines Revenue and Growth Rate (2016-2021)
Table Oceania Influenza Vaccines Sales Price Analysis (2016-2021)
Table Oceania Influenza Vaccines Consumption Volume by Types
Table Oceania Influenza Vaccines Consumption Structure by Application
Table Oceania Influenza Vaccines Consumption by Top Countries
Figure Australia Influenza Vaccines Consumption Volume from 2016 to 2021
Figure New Zealand Influenza Vaccines Consumption Volume from 2016 to 2021
Figure South America Influenza Vaccines Consumption and Growth Rate (2016-2021)
Figure South America Influenza Vaccines Revenue and Growth Rate (2016-2021)
Table South America Influenza Vaccines Sales Price Analysis (2016-2021)
Table South America Influenza Vaccines Consumption Volume by Types
Table South America Influenza Vaccines Consumption Structure by Application
Table South America Influenza Vaccines Consumption Volume by Major Countries
Figure Brazil Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Argentina Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Columbia Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Chile Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Venezuela Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Peru Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Puerto Rico Influenza Vaccines Consumption Volume from 2016 to 2021
Figure Ecuador Influenza Vaccines Consumption Volume from 2016 to 2021
AstraZeneca Influenza Vaccines Product Specification
AstraZeneca Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
CSL Influenza Vaccines Product Specification
CSL Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
GlaxoSmithKline Influenza Vaccines Product Specification
GlaxoSmithKline Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Sanofi Influenza Vaccines Product Specification
Table Sanofi Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Altimmune Influenza Vaccines Product Specification
Altimmune Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
BionVax Influenza Vaccines Product Specification
BionVax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
FluGen Influenza Vaccines Product Specification
FluGen Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
FOLIA BIOTECH Influenza Vaccines Product Specification
FOLIA BIOTECH Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Genentech Influenza Vaccines Product Specification
Genentech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Green Cross Influenza Vaccines Product Specification
Green Cross Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Medicago Influenza Vaccines Product Specification
Medicago Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Moderna Therapeutics Influenza Vaccines Product Specification
Moderna Therapeutics Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Novavax Influenza Vaccines Product Specification
Novavax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Specification
Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
SK Chemicals Influenza Vaccines Product Specification
SK Chemicals Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
UNM Pharma Influenza Vaccines Product Specification
UNM Pharma Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Vaccitech Influenza Vaccines Product Specification
Vaccitech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Vaxart Influenza Vaccines Product Specification
Vaxart Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Vaxine Pty Influenza Vaccines Product Specification
Vaxine Pty Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Visterra Influenza Vaccines Product Specification
Visterra Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Figure Global Influenza Vaccines Consumption Volume and Growth Rate Forecast (2022-2027)
Figure Global Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Table Global Influenza Vaccines Consumption Volume Forecast by Regions (2022-2027)
Table Global Influenza Vaccines Value Forecast by Regions (2022-2027)
Figure North America Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure North America Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure United States Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure United States Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Canada Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Canada Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Mexico Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Mexico Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure East Asia Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure East Asia Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure China Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure China Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Japan Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Japan Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure South Korea Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure South Korea Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Europe Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Europe Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Germany Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Germany Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure UK Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure UK Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure France Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure France Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Italy Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Italy Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Russia Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Russia Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Spain Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Spain Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Netherlands Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Netherlands Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Swizerland Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Swizerland Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Poland Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Poland Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure South Asia Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure South Asia a Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure India Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure India Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Pakistan Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Pakistan Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Bangladesh Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Bangladesh Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Southeast Asia Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Southeast Asia Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Indonesia Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Indonesia Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Thailand Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Thailand Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Singapore Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Singapore Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Malaysia Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Malaysia Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Philippines Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Philippines Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Vietnam Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Vietnam Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Myanmar Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Myanmar Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Middle East Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Middle East Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Turkey Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Turkey Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Saudi Arabia Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Saudi Arabia Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Iran Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Iran Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure United Arab Emirates Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure United Arab Emirates Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Israel Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Israel Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Iraq Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Iraq Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Qatar Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Qatar Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Kuwait Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Kuwait Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Oman Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Oman Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Africa Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Africa Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Nigeria Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Nigeria Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure South Africa Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure South Africa Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Egypt Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Egypt Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Algeria Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Algeria Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Morocco Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Morocco Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Oceania Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Oceania Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Australia Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Australia Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure New Zealand Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure New Zealand Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure South America Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure South America Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Brazil Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Brazil Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Argentina Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Argentina Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Columbia Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Columbia Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Chile Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Chile Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Venezuela Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Venezuela Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Peru Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Peru Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Puerto Rico Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Puerto Rico Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Figure Ecuador Influenza Vaccines Consumption and Growth Rate Forecast (2022-2027)
Figure Ecuador Influenza Vaccines Value and Growth Rate Forecast (2022-2027)
Table Global Influenza Vaccines Consumption Forecast by Type (2022-2027)
Table Global Influenza Vaccines Revenue Forecast by Type (2022-2027)
Figure Global Influenza Vaccines Price Forecast by Type (2022-2027)
Table Global Influenza Vaccines Consumption Volume Forecast by Application (2022-2027)
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices